# EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q1 Statement of Cash Flows

- Company: EDWARDS LIFESCIENCES CORPORATION (EW)
- Period: 2026-01-01 to 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-05-06, accession number 0001099800-26-000026
- Page: https://plicit.ai/financials/ew/fy2026-q1-cash-flow
- Chart image: https://plicit.ai/charts/ew-fy2026-q1-cash-flow-sankey.png

## Chart details

Cash flows for Jan 1, 2026 through Mar 31, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Mar 31, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Dec 31, 2025**: 2,939,500,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- **Operating activities**: 43,800,000 US dollars. Net cash provided.
- **Net income**: 380,700,000 US dollars
- **Depreciation and amortization**: 40,900,000 US dollars
- **Non-cash operating lease cost**: 6,500,000 US dollars
- **Stock-based compensation (Note 10)**: 45,400,000 US dollars
- **Loss on investments, net**: 3,500,000 US dollars
- **Deferred income taxes**: 9,400,000 US dollars
- **Gain on remeasurement of previously held interest upon acquisition (Note 7)**: negative 65,200,000 US dollars
- **Loss on impairment (Note 6)**: 123,600,000 US dollars
- **Other**: 500,000 US dollars
- **Accounts and other receivables, net**: negative 117,900,000 US dollars
- **Inventories**: negative 1,600,000 US dollars
- **Accounts payable and accrued liabilities**: negative 347,100,000 US dollars
- **Income taxes**: 41,900,000 US dollars
- **Prepaid expenses and other current assets**: negative 8,700,000 US dollars
- **Intellectual property agreement accrual**: negative 50,000,000 US dollars
- **Other**: negative 18,100,000 US dollars
- **Investing activities**: negative 92,800,000 US dollars. Net cash used.
- **Capital expenditures**: negative 64,900,000 US dollars
- **Investments in unconsolidated affiliates**: negative 6,300,000 US dollars
- **Purchases of held-to-maturity investments (Note 5)**: negative 12,500,000 US dollars
- **Proceeds from held-to-maturity investments (Note 5)**: 12,500,000 US dollars
- **Purchases of available-for-sale investments (Note 5)**: negative 641,100,000 US dollars
- **Proceeds from available-for-sale investments (Note 5)**: 710,100,000 US dollars
- **Payment for working capital adjustment and sale of product group (Note 4)**: 0 US dollars
- **Business combinations, net of cash (Note 7)**: negative 35,100,000 US dollars
- **Payment for acquisition options**: 0 US dollars
- **Issuances of notes receivable**: negative 55,200,000 US dollars
- **Other**: negative 300,000 US dollars
- **Financing activities**: negative 451,200,000 US dollars. Net cash used.
- **Purchases of treasury stock**: negative 421,800,000 US dollars
- **Equity forward contract related to accelerated share repurchase agreement (Note 11)**: negative 100,000,000 US dollars
- **Proceeds from stock plans**: 68,900,000 US dollars
- **Other**: 1,700,000 US dollars
- **Operating adjustment reconciliation**: 608,600,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing gross reconciliation**: 521,800,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing gross reconciliation**: 815,400,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **Exchange-rate effect**: 8,200,000 US dollars
- **Ending cash on Mar 31, 2026**: 2,447,500,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- **Cash sources and uses**: 2,991,500,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: negative 492,000,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: 0.12×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- **Operating cash flow**: 43,800,000 US dollars. Operating cash flow used in the free cash flow calculation.
- **Cash purchases of property, plant and equipment**: 64,900,000 US dollars. These cash purchases are already included in investing activities above.
- **Free cash flow**: negative 21,100,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income exceeds operating cash. The diagram allocates $43.80M of net income directly to operating cash and $336.90M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 43,800,000 US dollars minus 64,900,000 US dollars equals negative 21,100,000 US dollars.